Glooko entered into a partnership with Sanofi to integrate a connected cap for smart insulin pens into its digital platform for people with diabetes and their healthcare providers.

A new alliance between Glooko and Sanofi allows for visualization of connected pen data in the Glooko app that patients with diabetes can share with their healthcare team.

Glooko achieving ISO 27001 certification allows the digital health company to assure patients with diabetes and related chronic conditions that their health data remains secure on its data management and remote patient monitoring platforms.

Wearable technologies that were built for fitness have evolved and now have greater diagnostic and medical uses. Glooko Chief Executive Officer Russ Johannesson discusses why these products are at the heart of connected care, the growing areas of digital health, therapeutics and clinical research, and the increasing demand for and adoption of remote patient monitoring.

Remote patient monitoring is likely to become as essential to healthcare as mobile phones are to modern life. Glooko Chief Commercial Officer Zach Henderson discusses how medical practices can leverage the digital health solution to improve patient care, engagement and satisfaction while generating sizable and consistent revenues.

Glooko Chief Commercial Officer Zach Henderson shares the clinical and financial benefits of healthcare providers, health systems and payers leveraging remote patient monitoring technology to treat patients with chronic conditions.

The expansion of Academy™, a free educational programme from Glooko and the Diabetes Technology Network/Association of British Clinical Diabetologists, into Ireland will help clinicians further increase their knowledge and stay current on new diabetes technologies used to treat patients with the chronic condition.

Glooko announced, in partnership with the Diabetes Technology Network/Association of British Clinical Diabetologists, the expansion into Ireland of Academy™, an online programme focused on diabetes technology and education.

Device-integrating digital health platforms, like Glooko, help bridge diabetes care gaps and enable patients to better manage their condition.

Medidata announced ten highly innovative organizations, including Glooko, have joined its groundbreaking Sensor Cloud Network. The company is making it easier for life science organizations to execute global clinical trials through its Connected Research platform.